Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer
Clinical trial NCT00217672 · COMPLETED
Trial details
- NCT number
- NCT00217672
- Sponsor
- Translational Oncology Research International
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2008-12-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.